Dacarbazine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 22.04.2021

Dieser Artikel auf Deutsch

Synonym(s)

DTIC

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antimetabolite, prodrug.

Half-lifeThis section has been translated automatically.

5 h

IndicationThis section has been translated automatically.

Metastatic malignant melanoma as mono- or combination therapy, sarcomas, M. Hodgkin.

Dosage and method of useThis section has been translated automatically.

  • According to chemotherapy protocol:
    • monotherapy:
      • 200-250 mg/m2 KO/day IV, day 1-5, every 21-28 days.
      • 850-1200 mg/m2 KO/day i.v., day 1, every 21-28 days.
  • In combination therapies according to the following schemes:
    • BHD, BVD, BOLD, DVP, DBCT, DTIC-INFα, DTIC-IL2.

Remember! Women and men must use effective contraception during the therapy and until 6 months after the end of the therapy. In the case of high-dose chemotherapy, men should have a spermiogram before and after therapy and be made aware of the possibility of cryopreserving sperm!

Undesirable effectsThis section has been translated automatically.

  • Cutaneous adverse reactions: photosensitivity, pruritus, erythema, allergic reactions.
  • Extracutaneous UAWs: BB changes, gastrointestinal disturbances, Budd-Chiari syndrome, renal damage, headache, flu-like symptoms, transaminase elevation.

Reminder. During therapy, regular checks of GOT and GPT as well as blood count!

In the event of a sudden increase in transaminases or eosinophilia > 30%, discontinue dacarbazine and administer glucocorticoids and heparin !

InteractionsThis section has been translated automatically.

Cytostatic drugs lead to a mutual increase in toxicity.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, leukopenia and/or thrombopenia, severe liver or kidney disease.

PreparationsThis section has been translated automatically.

Detimedac

LiteratureThis section has been translated automatically.

  1. Hauschild A et al (2008) systemic therapy of melanoma. Current clinical studies. dermatologist 59: 484-492

Authors

Last updated on: 22.04.2021